---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-094344"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:18:46.429633+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals appoints Vinay Shah as CFO effective Nov 16, 2024; Joseph Truluck resigns

## Summary
- CFO Joseph Truluck resigns effective Nov 15, 2024; will serve as consultant through Mar 31, 2025.
- Vinay Shah appointed CFO effective Nov 16, 2024, with a 3-year employment term.
- Shah receives $315K annual base salary, up to 30% discretionary bonus, and 40,000 stock options.
- Shah previously served as CFO at Virpax (VRPX) and Aravive (ARAV), with over 25 years industry experience.
- Truluck's resignation was not due to any disagreement with the company over operations or accounting.

## SEC filing metadata
- accession: 0001213900-24-094344
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390024094344/0001213900-24-094344-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390024094344/ea0219983-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-094344
- JSON: https://secwatch.observer/filing/0001213900-24-094344.json
- Plain text: https://secwatch.observer/filing/0001213900-24-094344.txt

## Key facts
- Executive change
  Joseph Truluck resigned as Chief Financial Officer at ADIAL PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: he would serve until November 15, 2024 as the Company’s Chief Financial Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390024094344/0001213900-24-094344-index.htm
- Executive change
  Vinay Shah was appointed as Chief Financial Officer at ADIAL PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On November 1, 2024, the Company’s board of directors effective November 16, 2024 appointed Vinay Shah, age 61, as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390024094344/0001213900-24-094344-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.